Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.25%32.77M | 0.56%31.53M | 7.29%29.89M | 43.78%31.43M | 61.06%31.35M | 37.68%27.86M | 17.02%85.56M | 24M | 21.86M | 2.26%19.47M |
Cost of revenue | 10.98%11.12M | 10.74%10.68M | 17.00%10.18M | 60.09%10.02M | 65.72%9.64M | 48.15%8.7M | 23.18%25.22M | 7.27M | 6.26M | 12.97%5.82M |
Gross profit | 1.11%21.65M | -3.96%20.85M | 2.89%19.71M | 37.24%21.41M | 59.08%21.71M | 33.40%19.16M | 14.63%60.34M | 16.73M | 15.6M | -1.71%13.65M |
Operating expense | 4.63%19.97M | 0.97%18.78M | 3.15%17.85M | 50.61%19.09M | 60.26%18.6M | 41.85%17.31M | 6.56%47.71M | 11.24M | 12.67M | 5.73%11.6M |
Selling and administrative expenses | -0.19%19.02M | 1.28%18.76M | 2.85%17.88M | 35.19%19.05M | 71.61%18.52M | 43.78%17.38M | 19.25%53.05M | --16.08M | --14.09M | -6.00%10.79M |
-Selling and marketing expense | 1.00%5.38M | -6.83%4.95M | 19.36%4.61M | 53.99%5.32M | 66.21%5.32M | 24.64%3.86M | 25.47%13.2M | --3.45M | --3.46M | 0.85%3.2M |
-General and administrative expense | -0.65%13.64M | 4.55%13.81M | -1.86%13.27M | 29.09%13.73M | 73.89%13.21M | 50.37%13.52M | 17.32%39.86M | --12.63M | --10.64M | -8.62%7.59M |
Other operating expenses | 2,226.83%954K | -61.73%31K | --13K | -81.02%41K | -90.01%81K | ---- | -36.78%275K | ---67K | --216K | 1,786.05%811K |
Total other operating income | ---- | 133.33%14K | -47.37%40K | -99.63%6K | --6K | --76K | 3,618.54%5.62M | --4.78M | --1.64M | ---- |
Operating profit | -27.77%1.68M | -33.37%2.08M | 0.43%1.86M | -20.59%2.33M | 52.35%3.11M | -14.29%1.85M | 60.54%12.63M | 5.49M | 2.93M | -29.76%2.04M |
Net non-operating interest income (expenses) | -13.98%-106K | -191.78%-67K | -4.88%-86K | -14.81%-93K | 221.67%73K | -24.24%-82K | 29.59%-257K | -50K | -81K | 39.39%-60K |
Non-operating interest income | 14.29%8K | -92.86%13K | 66.67%5K | --7K | 18,100.00%182K | 200.00%3K | 800.00%27K | --25K | --0 | --1K |
Non-operating interest expense | 14.00%114K | -26.61%80K | 7.06%91K | 23.46%100K | 78.69%109K | 26.87%85K | -22.83%284K | --75K | --81K | -38.38%61K |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 0 | 0 | 0 | -80.00%4K | -115.00%-6K | 89.33%-8K | -166.67%-34K | -19K | 20K | 147.06%40K |
Special income (charges) | ||||||||||
Other non-operating income (expenses) | ||||||||||
Income before tax | -29.64%1.57M | -36.88%2.01M | 0.68%1.78M | -22.00%2.24M | 57.16%3.18M | -12.76%1.76M | 63.36%12.34M | 5.42M | 2.87M | -25.75%2.02M |
Income tax | -5.55%783K | -6.94%872K | -16.43%600K | 45.44%829K | 38.00%937K | -7.12%718K | -24.33%1.94M | -84K | 570K | -5.43%679K |
Net income | -43.82%791K | -49.38%1.14M | 12.43%1.18M | -38.73%1.41M | 66.84%2.24M | -16.25%1.05M | 108.36%10.4M | 5.51M | 2.3M | -33.02%1.35M |
Net income continuous operations | -43.82%791K | -49.38%1.14M | 12.43%1.18M | -38.73%1.41M | 66.84%2.24M | -16.25%1.05M | 108.36%10.4M | --5.51M | --2.3M | -33.02%1.35M |
Noncontrolling interests | -22.83%71K | -19.26%109K | 750.00%65K | 9,100.00%92K | 1,400.00%135K | -25.00%-10K | -80.00%8K | 6K | 1K | 200.00%9K |
Net income attributable to the company | -45.29%720K | -51.30%1.03M | 5.21%1.11M | -42.71%1.32M | 57.86%2.11M | -15.99%1.06M | 109.88%10.39M | 5.5M | 2.3M | -33.37%1.34M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -45.29%720K | -51.30%1.03M | 5.21%1.11M | -42.71%1.32M | 57.86%2.11M | -15.99%1.06M | 109.88%10.39M | 5.5M | 2.3M | -33.37%1.34M |
Gross dividend payment | ||||||||||
Basic earnings per share | 5,212.50%3.23 | -53.39%0.0461 | 2.42%0.0507 | -47.08%0.0608 | 47.83%0.0989 | -21.55%0.0495 | 66.57%0.5172 | 0.2723 | 0.1149 | -47.01%0.0669 |
Diluted earnings per share | 5,196.05%3.22 | -53.49%0.046 | 2.02%0.0505 | -47.08%0.0608 | 47.83%0.0989 | -21.55%0.0495 | 66.57%0.5172 | 0.258 | 0.1149 | -47.01%0.0669 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |